- Home
- LFVN vs NVCT Comparison
LFVN vs NVCT Comparison
Compare LFVN & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- NVCT
- Stock Information
- Founded
- LFVN N/A
- NVCT 2020
- Country
- LFVN United States
- NVCT United States
- Employees
- LFVN N/A
- NVCT N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- LFVN Health Care
- NVCT Health Care
- Exchange
- LFVN Nasdaq
- NVCT Nasdaq
- Market Cap
- LFVN 127.0M
- NVCT 119.4M
- IPO Year
- LFVN N/A
- NVCT 2022
- Fundamental
- Price
- LFVN $13.83
- NVCT $4.95
- Analyst Decision
- LFVN
- NVCT Strong Buy
- Analyst Count
- LFVN 0
- NVCT 1
- Target Price
- LFVN N/A
- NVCT $21.00
- AVG Volume (30 Days)
- LFVN 121.1K
- NVCT 320.8K
- Earning Date
- LFVN 10-29-2024
- NVCT 11-05-2024
- Dividend Yield
- LFVN 1.16%
- NVCT N/A
- EPS Growth
- LFVN 59.77
- NVCT N/A
- EPS
- LFVN 0.32
- NVCT N/A
- Revenue
- LFVN $196,014,000.00
- NVCT N/A
- Revenue This Year
- LFVN $4.36
- NVCT N/A
- Revenue Next Year
- LFVN $3.85
- NVCT N/A
- P/E Ratio
- LFVN $43.28
- NVCT N/A
- Revenue Growth
- LFVN N/A
- NVCT N/A
- 52 Week Low
- LFVN $5.05
- NVCT $4.83
- 52 Week High
- LFVN $15.15
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- LFVN 57.69
- NVCT 35.48
- Support Level
- LFVN $13.54
- NVCT $6.00
- Resistance Level
- LFVN $15.15
- NVCT $11.80
- Average True Range (ATR)
- LFVN 0.98
- NVCT 1.23
- MACD
- LFVN -0.04
- NVCT -0.27
- Stochastic Oscillator
- LFVN 69.44
- NVCT 1.72
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.